Symbols / ILMN Stock $161.38 -0.34% Illumina, Inc.

Healthcare • Diagnostics & Research • United States • NMS
ILMN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Jacob Thaysen Ph.D.
Exch · Country NMS · United States
Market Cap 24.42B
Enterprise Value 25.81B
Income 853.00M
Sales 4.39B
FCF (ttm) 845.63M
Book/sh 17.61
Cash/sh 7.63
Employees 8,600
Insider 10d —
IPO Jul 28, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 29.34
Forward P/E 27.20
PEG 2.84
P/S 5.56
P/B 9.17
P/C —
EV/EBITDA 22.34
EV/Sales 5.87
Quick Ratio 1.23
Current Ratio 1.75
Debt/Eq 95.07
LT Debt/Eq —
EPS (ttm) 5.50
EPS next Y 5.93
EPS Growth 6.10%
Revenue Growth 4.80%
EPS Gr Q/Q 2.30%
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-04-30
ROA 8.68%
ROE 33.82%
ROIC —
Gross Margin 68.29%
Oper. Margin 18.33%
Profit Margin 19.42%
Shs Outstand 151.30M
Shs Float 148.03M
Insider Own 0.20%
Instit Own 106.53%
Short Float 8.34%
Short Ratio 4.24
Short Interest 7.72M
52W High 177.22
vs 52W High -8.94%
52W Low 88.00
vs 52W Low 83.39%
Beta 1.49
Impl. Vol. 44.01%
Rel Volume 1.05
Avg Volume 1.67M
Volume 1.75M
Target (mean) $148.56
Tgt Median $155.00
Tgt Low $95.00
Tgt High $185.00
# Analysts 18
Recom Buy
Prev Close $161.93
Price $161.38
Change -0.34%
About

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$148.56
Mean price target
2. Current target
$161.38
Latest analyst target
3. DCF / Fair value
$100.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$161.38
Low
$95.00
High
$185.00
Mean
$148.56

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-10 up JP Morgan Neutral → Overweight $185
2026-06-01 main Guggenheim Buy → Buy $180
2026-05-04 main Citigroup Sell → Sell $95
2026-05-01 main Canaccord Genuity Hold → Hold $140
2026-05-01 main JP Morgan Neutral → Neutral $125
2026-05-01 main Barclays Underweight → Underweight $122
2026-05-01 main Evercore ISI Group Outperform → Outperform $155
2026-02-09 main Piper Sandler Overweight → Overweight $170
2026-02-06 main JP Morgan Neutral → Neutral $120
2026-01-26 main Guggenheim Buy → Buy $170
2026-01-26 main Canaccord Genuity Hold → Hold $150
2026-01-20 main Stifel Buy → Buy $155
2026-01-07 main TD Cowen Hold → Hold $140
2026-01-05 main Guggenheim Buy → Buy $144
2025-12-22 main Canaccord Genuity Hold → Hold $130
2025-12-15 main Barclays Underweight → Underweight $110
2025-12-15 main JP Morgan Neutral → Neutral $130
2025-10-31 main Barclays Underweight → Underweight $100
2025-10-31 main Canaccord Genuity Hold → Hold $112
2025-10-31 main JP Morgan Neutral → Neutral $105
News
RSS: Latest ILMN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-05 LECKMAN PATRICIA Officer — 783 $161.79 $127,305
2026-06-02 LECKMAN PATRICIA Officer — 784 $160.66 $127,068
2026-06-01 MEISTER KEITH A Director — 669,596 $147.50 $107,042,631
2026-05-29 ERICKSEN SCOTT D Officer — 2,000 $150.10 $305,150
2026-05-29 DAVIES SCOTT M Officer — 615 $160.00 $98,400
2026-05-28 MEISTER KEITH A Director — 24,562 $102.82 $2,525,465
2026-05-21 GOTTLIEB SCOTT Director — 2,072 $144.83 $300,088
2026-05-21 ULLEM SCOTT B Director — 2,072 $144.83 $300,088
2026-05-21 MEISTER KEITH A Director — 2,072 $144.83 $300,088
2026-05-21 KING DAVID P Director — 2,072 $144.83 $300,088
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4,343.00
-0.66%
4,372.00
-2.93%
4,504.00
-1.75%
4,584.00
Operating Revenue
4,343.00
-0.66%
4,372.00
-2.93%
4,504.00
-1.75%
4,584.00
Cost Of Revenue
1,473.00
-2.51%
1,511.00
-14.15%
1,760.00
+9.18%
1,612.00
Reconciled Cost Of Revenue
1,473.00
-2.51%
1,511.00
-14.15%
1,760.00
+9.18%
1,612.00
Gross Profit
2,870.00
+0.31%
2,861.00
+4.26%
2,744.00
-7.67%
2,972.00
Operating Expense
2,053.00
-9.20%
2,261.00
-23.77%
2,966.00
+13.29%
2,618.00
Research And Development
967.00
-17.28%
1,169.00
-13.66%
1,354.00
+2.50%
1,321.00
Selling General And Administration
1,086.00
-0.55%
1,092.00
-32.26%
1,612.00
+24.29%
1,297.00
Total Expenses
3,526.00
-6.52%
3,772.00
-20.19%
4,726.00
+11.73%
4,230.00
Operating Income
817.00
+36.17%
600.00
+370.27%
-222.00
-162.71%
354.00
Total Operating Income As Reported
807.00
+196.88%
-833.00
+22.08%
-1,069.00
+74.42%
-4,179.00
EBITDA
1,457.00
+300.97%
-725.00
-19.24%
-608.00
+84.47%
-3,916.00
Normalized EBITDA
1,467.00
+107.20%
708.00
+196.23%
239.00
-61.26%
617.00
Reconciled Depreciation
270.00
-23.73%
354.00
-18.06%
432.00
+9.64%
394.00
EBIT
1,187.00
+210.01%
-1,079.00
-3.75%
-1,040.00
+75.87%
-4,310.00
Total Unusual Items
-10.00
+99.30%
-1,433.00
-69.19%
-847.00
+81.31%
-4,533.00
Total Unusual Items Excluding Goodwill
-10.00
+99.30%
-1,433.00
-69.19%
-847.00
+81.31%
-4,533.00
Special Income Charges
-10.00
+99.30%
-1,433.00
-69.19%
-847.00
+81.31%
-4,533.00
Other Special Charges
10.00
+102.19%
-456.00
-2380.00%
20.00
-96.77%
619.00
Impairment Of Capital Assets
0.00
-100.00%
1,889.00
+128.42%
827.00
-78.87%
3,914.00
Restructuring And Mergern Acquisition
—
—
0.00
0.00
Net Income
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Pretax Income
1,086.00
+192.11%
-1,179.00
-5.55%
-1,117.00
+74.24%
-4,336.00
Net Non Operating Interest Income Expense
-61.00
-12.96%
-54.00
-184.21%
-19.00
-26.67%
-15.00
Interest Expense Non Operating
101.00
+1.00%
100.00
+29.87%
77.00
+196.15%
26.00
Net Interest Income
-61.00
-12.96%
-54.00
-184.21%
-19.00
-26.67%
-15.00
Interest Expense
101.00
+1.00%
100.00
+29.87%
77.00
+196.15%
26.00
Interest Income Non Operating
40.00
-13.04%
46.00
-20.69%
58.00
+427.27%
11.00
Interest Income
40.00
-13.04%
46.00
-20.69%
58.00
+427.27%
11.00
Other Income Expense
330.00
+119.13%
-1,725.00
-96.92%
-876.00
+81.26%
-4,675.00
Other Non Operating Income Expenses
340.00
+216.44%
-292.00
-906.90%
-29.00
+79.58%
-142.00
Gain On Sale Of Security
—
—
-30.00
+76.74%
-129.00
Gain On Sale Of Business
—
—
—
—
Tax Provision
236.00
+436.36%
44.00
+0.00%
44.00
-35.29%
68.00
Tax Rate For Calcs
0.00
+3.48%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-2.17
+99.28%
-300.93
-69.19%
-177.87
+81.31%
-951.93
Net Income Including Noncontrolling Interests
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Net Income From Continuing Operation Net Minority Interest
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Net Income From Continuing And Discontinued Operation
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Net Income Continuous Operations
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Minority Interests
—
—
—
—
Normalized Income
857.83
+1043.39%
-90.93
+81.51%
-491.87
+40.23%
-822.93
Net Income Common Stockholders
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Diluted EPS
5.45
+170.87%
-7.69
-4.77%
-7.34
+73.79%
-28.00
Basic EPS
5.47
+171.13%
-7.69
-4.77%
-7.34
+73.79%
-28.00
Basic Average Shares
155.00
-2.52%
159.00
+0.63%
158.00
+0.64%
157.00
Diluted Average Shares
156.00
-1.89%
159.00
+0.63%
158.00
+0.64%
157.00
Diluted NI Availto Com Stockholders
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,644.00
+5.41%
6,303.00
-37.66%
10,111.00
-17.47%
12,252.00
Current Assets
3,289.00
+19.77%
2,746.00
+5.25%
2,609.00
-26.73%
3,561.00
Cash Cash Equivalents And Short Term Investments
1,633.00
+33.85%
1,220.00
+15.75%
1,054.00
-48.26%
2,037.00
Cash And Cash Equivalents
1,418.00
+25.82%
1,127.00
+7.54%
1,048.00
-47.89%
2,011.00
Other Short Term Investments
215.00
+131.18%
93.00
+1450.00%
6.00
-76.92%
26.00
Receivables
854.00
+16.19%
735.00
+0.14%
734.00
+9.39%
671.00
Accounts Receivable
854.00
+16.19%
735.00
+0.14%
734.00
+9.39%
671.00
Gross Accounts Receivable
861.00
+15.73%
744.00
+0.40%
741.00
+9.78%
675.00
Allowance For Doubtful Accounts Receivable
-7.00
+22.22%
-9.00
-28.57%
-7.00
-75.00%
-4.00
Inventory
564.00
+3.11%
547.00
-6.81%
587.00
+3.35%
568.00
Raw Materials
254.00
+12.89%
225.00
-18.48%
276.00
+11.74%
247.00
Work In Process
398.00
-1.49%
404.00
+0.50%
402.00
+4.15%
386.00
Finished Goods
45.00
+45.16%
31.00
+3.33%
30.00
+7.14%
28.00
Prepaid Assets
—
—
—
—
Other Current Assets
238.00
-2.46%
244.00
+4.27%
234.00
-17.89%
285.00
Total Non Current Assets
3,355.00
-5.68%
3,557.00
-52.59%
7,502.00
-13.68%
8,691.00
Net PPE
1,129.00
-8.51%
1,234.00
-20.44%
1,551.00
-11.07%
1,744.00
Gross PPE
2,492.00
+0.16%
2,488.00
-7.47%
2,689.00
-0.63%
2,706.00
Accumulated Depreciation
-1,363.00
-8.69%
-1,254.00
-10.19%
-1,138.00
-18.30%
-962.00
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
44.00
+0.00%
44.00
+0.00%
44.00
+0.00%
44.00
Machinery Furniture Equipment
1,241.00
+2.22%
1,214.00
+1.00%
1,202.00
+7.51%
1,118.00
Construction In Progress
82.00
+110.26%
39.00
-59.38%
96.00
-27.27%
132.00
Other Properties
370.00
-11.69%
419.00
-22.98%
544.00
-16.69%
653.00
Leases
755.00
-2.20%
772.00
-3.86%
803.00
+5.80%
759.00
Goodwill And Other Intangible Assets
1,323.00
-6.04%
1,408.00
-74.58%
5,538.00
-15.11%
6,524.00
Goodwill
1,113.00
+0.00%
1,113.00
-56.27%
2,545.00
-21.43%
3,239.00
Other Intangible Assets
210.00
-28.81%
295.00
-90.14%
2,993.00
-8.89%
3,285.00
Non Current Deferred Assets
454.00
-19.93%
567.00
+912.50%
56.00
—
Non Current Deferred Taxes Assets
454.00
-19.93%
567.00
+912.50%
56.00
—
Other Non Current Assets
449.00
+29.02%
348.00
-2.52%
357.00
-15.60%
423.00
Total Liabilities Net Minority Interest
3,921.00
-0.23%
3,930.00
-9.99%
4,366.00
-22.77%
5,653.00
Current Liabilities
1,585.00
+2.46%
1,547.00
-1.46%
1,570.00
-43.38%
2,773.00
Payables And Accrued Expenses
489.00
+7.00%
457.00
-54.71%
1,009.00
-0.69%
1,016.00
Payables
347.00
+7.76%
322.00
-0.62%
324.00
-16.92%
390.00
Accounts Payable
240.00
+8.60%
221.00
-9.80%
245.00
-16.38%
293.00
Current Accrued Expenses
142.00
+5.19%
135.00
-80.29%
685.00
+9.42%
626.00
Pensionand Other Post Retirement Benefit Plans Current
249.00
-1.19%
252.00
+13.00%
223.00
+18.62%
188.00
Total Tax Payable
107.00
+5.94%
101.00
+27.85%
79.00
-18.56%
97.00
Current Debt And Capital Lease Obligation
577.00
-0.17%
578.00
+572.09%
86.00
-93.50%
1,324.00
Current Debt
499.00
+0.00%
499.00
—
1,248.00
Other Current Borrowings
499.00
+0.00%
499.00
—
1,248.00
Current Capital Lease Obligation
78.00
-1.27%
79.00
-8.14%
86.00
+13.16%
76.00
Current Deferred Liabilities
270.00
+3.85%
260.00
+3.17%
252.00
+2.86%
245.00
Current Deferred Revenue
270.00
+3.85%
260.00
+3.17%
252.00
+2.86%
245.00
Total Non Current Liabilities Net Minority Interest
2,336.00
-1.97%
2,383.00
-14.77%
2,796.00
-2.92%
2,880.00
Long Term Debt And Capital Lease Obligation
1,976.00
-3.33%
2,044.00
-6.07%
2,176.00
-2.47%
2,231.00
Long Term Debt
1,490.00
+0.00%
1,490.00
+0.07%
1,489.00
+0.13%
1,487.00
Long Term Capital Lease Obligation
486.00
-12.27%
554.00
-19.36%
687.00
-7.66%
744.00
Other Non Current Liabilities
360.00
+6.19%
339.00
-45.32%
620.00
-4.47%
649.00
Stockholders Equity
2,723.00
+14.75%
2,373.00
-58.69%
5,745.00
-12.94%
6,599.00
Common Stock Equity
2,723.00
+14.75%
2,373.00
-58.69%
5,745.00
-12.94%
6,599.00
Capital Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Common Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
201.00
+0.50%
200.00
+0.50%
199.00
+0.51%
198.00
Ordinary Shares Number
153.00
-3.77%
159.00
+0.00%
159.00
+0.63%
158.00
Treasury Shares Number
48.00
+17.07%
41.00
+2.50%
40.00
+0.00%
40.00
Additional Paid In Capital
7,822.00
+3.95%
7,525.00
-21.25%
9,555.00
+3.78%
9,207.00
Retained Earnings
-392.00
+68.44%
-1,242.00
-6436.84%
-19.00
-101.66%
1,142.00
Gains Losses Not Affecting Retained Earnings
-10.00
-145.45%
22.00
+2300.00%
-1.00
-133.33%
3.00
Treasury Stock
4,699.00
+19.45%
3,934.00
+3.74%
3,792.00
+0.99%
3,755.00
Other Equity Adjustments
-10.00
-145.45%
22.00
+2300.00%
-1.00
-133.33%
3.00
Total Equity Gross Minority Interest
2,723.00
+14.75%
2,373.00
-58.69%
5,745.00
-12.94%
6,599.00
Total Capitalization
4,213.00
+9.06%
3,863.00
-46.60%
7,234.00
-10.54%
8,086.00
Working Capital
1,704.00
+42.12%
1,199.00
+15.40%
1,039.00
+31.85%
788.00
Invested Capital
4,712.00
+8.02%
4,362.00
-39.70%
7,234.00
-22.50%
9,334.00
Total Debt
2,553.00
-2.63%
2,622.00
+15.92%
2,262.00
-36.37%
3,555.00
Net Debt
571.00
-33.76%
862.00
+95.46%
441.00
-39.09%
724.00
Capital Lease Obligations
564.00
-10.90%
633.00
-18.11%
773.00
-5.73%
820.00
Net Tangible Assets
1,400.00
+45.08%
965.00
+366.18%
207.00
+176.00%
75.00
Tangible Book Value
1,400.00
+45.08%
965.00
+366.18%
207.00
+176.00%
75.00
Current Notes Payable
—
—
—
500.00
Inventories Adjustments Allowances
-133.00
-17.70%
-113.00
+6.61%
-121.00
-30.11%
-93.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,079.00
+28.91%
837.00
+75.10%
478.00
+21.94%
392.00
Cash Flow From Continuing Operating Activities
1,079.00
+28.91%
837.00
+75.10%
478.00
+21.94%
392.00
Net Income From Continuing Operations
850.00
+169.50%
-1,223.00
-5.34%
-1,161.00
+73.64%
-4,404.00
Depreciation Amortization Depletion
270.00
-23.73%
354.00
-18.06%
432.00
+9.64%
394.00
Depreciation
203.00
-9.38%
224.00
-4.68%
235.00
+9.30%
215.00
Amortization Cash Flow
67.00
-48.46%
130.00
-34.01%
197.00
+10.06%
179.00
Depreciation And Amortization
270.00
-23.73%
354.00
-18.06%
432.00
+9.64%
394.00
Amortization Of Intangibles
67.00
-48.46%
130.00
-34.01%
197.00
+10.06%
179.00
Other Non Cash Items
19.00
+106.01%
-316.00
-1758.82%
-17.00
+91.05%
-190.00
Stock Based Compensation
275.00
-25.68%
370.00
-2.63%
380.00
+3.83%
366.00
Asset Impairment Charge
27.00
-98.60%
1,935.00
+108.74%
927.00
-76.37%
3,923.00
Deferred Tax
119.00
+206.25%
-112.00
-239.39%
-33.00
-43.48%
-23.00
Deferred Income Tax
119.00
+206.25%
-112.00
-239.39%
-33.00
-43.48%
-23.00
Operating Gains Losses
-328.00
-205.13%
312.00
+680.00%
40.00
-67.21%
122.00
Gain Loss On Investment Securities
-328.00
-205.13%
312.00
+680.00%
40.00
-67.21%
122.00
Unrealized Gain Loss On Investment Securities
—
—
22.00
+2100.00%
1.00
Change In Working Capital
-153.00
+68.32%
-483.00
-436.67%
-90.00
-144.12%
204.00
Change In Receivables
-108.00
-332.00%
-25.00
+37.50%
-40.00
-233.33%
-12.00
Changes In Account Receivables
-108.00
-332.00%
-25.00
+37.50%
-40.00
-233.33%
-12.00
Change In Inventory
-17.00
-189.47%
19.00
+195.00%
-20.00
+85.19%
-135.00
Change In Prepaid Assets
-8.00
+42.86%
-14.00
-227.27%
11.00
-31.25%
16.00
Change In Payables And Accrued Expense
2.00
+100.45%
-444.00
-1431.03%
-29.00
-108.45%
343.00
Change In Accrued Expense
0.00
+100.00%
-440.00
-3033.33%
15.00
-96.06%
381.00
Change In Payable
2.00
+150.00%
-4.00
+90.91%
-44.00
-15.79%
-38.00
Change In Account Payable
2.00
+150.00%
-4.00
+90.91%
-44.00
-15.79%
-38.00
Change In Other Working Capital
-34.00
-6.25%
-32.00
-100.00%
-16.00
-100.00%
-8.00
Change In Other Current Assets
-21.00
-40.00%
-15.00
-400.00%
5.00
-73.68%
19.00
Change In Other Current Liabilities
33.00
+17.86%
28.00
+2900.00%
-1.00
+94.74%
-19.00
Investing Cash Flow
-55.00
+69.10%
-178.00
+22.94%
-231.00
+60.91%
-591.00
Cash Flow From Continuing Investing Activities
-55.00
+69.10%
-178.00
+22.94%
-231.00
+60.91%
-591.00
Net PPE Purchase And Sale
-148.00
-15.63%
-128.00
+34.36%
-195.00
+31.82%
-286.00
Purchase Of PPE
-148.00
-15.63%
-128.00
+34.36%
-195.00
+31.82%
-286.00
Capital Expenditure
-148.00
-15.63%
-128.00
+34.36%
-195.00
+31.82%
-286.00
Net Investment Purchase And Sale
103.00
+298.08%
-52.00
-766.67%
-6.00
+85.00%
-40.00
Purchase Of Investment
—
-52.00
-766.67%
-6.00
+85.00%
-40.00
Sale Of Investment
—
—
0.00
0.00
Net Business Purchase And Sale
-10.00
-600.00%
2.00
+106.67%
-30.00
+88.68%
-265.00
Purchase Of Business
-10.00
+87.65%
-81.00
-170.00%
-30.00
+88.68%
-265.00
Gain Loss On Sale Of Business
—
—
—
—
Net Intangibles Purchase And Sale
—
—
-1.00
+99.44%
-180.00
Purchase Of Intangibles
—
—
-1.00
+99.44%
-180.00
Financing Cash Flow
-744.00
-30.53%
-570.00
+52.89%
-1,210.00
-221.00%
1,000.00
Cash Flow From Continuing Financing Activities
-744.00
-30.53%
-570.00
+52.89%
-1,210.00
-221.00%
1,000.00
Net Issuance Payments Of Debt
-5.00
-101.02%
491.00
+139.72%
-1,236.00
-224.72%
991.00
Issuance Of Debt
495.00
-60.11%
1,241.00
0.00
-100.00%
991.00
Repayment Of Debt
-500.00
+33.33%
-750.00
+39.32%
-1,236.00
0.00
Long Term Debt Issuance
495.00
-60.11%
1,241.00
0.00
-100.00%
991.00
Long Term Debt Payments
-500.00
+33.33%
-750.00
+39.32%
-1,236.00
0.00
Net Long Term Debt Issuance
-5.00
-101.02%
491.00
+139.72%
-1,236.00
-224.72%
991.00
Net Common Stock Issuance
-698.00
-1063.33%
-60.00
-189.55%
67.00
+6.35%
63.00
Common Stock Payments
-742.00
-539.66%
-116.00
0.00
0.00
Repurchase Of Capital Stock
-742.00
-539.66%
-116.00
0.00
0.00
Net Other Financing Charges
-41.00
+95.90%
-1,001.00
-2341.46%
-41.00
+24.07%
-54.00
Changes In Cash
280.00
+214.61%
89.00
+109.24%
-963.00
-220.22%
801.00
Effect Of Exchange Rate Changes
11.00
+210.00%
-10.00
0.00
+100.00%
-22.00
Beginning Cash Position
1,127.00
+7.54%
1,048.00
-47.89%
2,011.00
+63.23%
1,232.00
End Cash Position
1,418.00
+25.82%
1,127.00
+7.54%
1,048.00
-47.89%
2,011.00
Free Cash Flow
931.00
+31.31%
709.00
+150.53%
283.00
+166.98%
106.00
Interest Paid Supplemental Data
95.00
+14.46%
83.00
+13.70%
73.00
+329.41%
17.00
Income Tax Paid Supplemental Data
73.00
-30.48%
105.00
+61.54%
65.00
-46.72%
122.00
Common Stock Issuance
44.00
-21.43%
56.00
-16.42%
67.00
+6.35%
63.00
Earnings Losses From Equity Investments
—
—
0.00
0.00
Issuance Of Capital Stock
44.00
-21.43%
56.00
-16.42%
67.00
+6.35%
63.00
Sale Of Business
0.00
-100.00%
83.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category